Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	31,832	24,021	29,238	20,282	15,100	12,840
Market Cap Growth	59.50%	-17.84%	44.16%	34.32%	17.60%	74.32%
Enterprise Value	32,035	24,278	29,564	19,873	14,639	11,424
Last Close Price	248.79	191.41	237.65	169.58	129.97	115.17
PS Ratio	15.06	13.14	28.18	24.02	30.64	58.43
PB Ratio	1091.32	-108.87	-184.79	34.48	14.86	8.92
P/TBV Ratio	1091.32	-	-	34.48	14.86	8.92
P/FCF Ratio	1997.71	572.67	-	-	-	-
P/OCF Ratio	567.40	230.62	-	-	-	-
EV/Sales Ratio	15.29	13.28	28.50	23.54	29.70	51.99
EV/FCF Ratio	1994.34	578.81	-	-	-	-
Debt / Equity Ratio	84.26	-12.16	-16.51	3.72	1.57	0.21
Debt / FCF Ratio	169.72	63.96	-	-	-	-
Asset Turnover	0.52	0.50	0.29	0.24	0.17	0.11
Inventory Turnover	3.57	2.85	1.57	1.73	1.19	0.62
Quick Ratio	2.57	2.86	3.16	3.79	4.23	4.48
Current Ratio	2.75	3.08	3.51	4.04	4.47	4.87
Return on Equity (ROE)	-	-	-526.14%	-106.31%	-69.92%	-64.66%
Return on Assets (ROA)	-2.92%	-4.78%	-13.65%	-12.56%	-17.85%	-29.58%
Return on Capital (ROIC)	-4.47%	-7.17%	-18.77%	-16.46%	-23.80%	-38.19%
Earnings Yield	-1.04%	-1.83%	-3.87%	-4.20%	-5.68%	-6.90%
FCF Yield	0.05%	0.17%	-2.10%	-3.54%	-4.54%	-3.26%
Buyback Yield / Dilution	-1.97%	-2.64%	-2.73%	-3.01%	-5.24%	-8.62%
Total Shareholder Return	-1.97%	-2.64%	-2.73%	-3.01%	-5.24%	-8.62%

Source: S&P Capital IQ. Standard template. Financial Sources.